Sorry, you need to enable JavaScript to visit this website.

    Pfizer Declares First-Quarter 2014 Dividend

    Board of Directors Approves Increase in Quarterly Cash Dividend to $0.26 Per Share

    The board of directors of Pfizer Inc. today declared a 26-cent first-quarter 2014 dividend on the company’s common stock, payable March 4, 2014, to shareholders of record at the close of business on February 7, 2014.  Pfizer increased the dividend by more than 8 percent, to 26 cents from 24 cents per share.
     
    The first-quarter 2014 cash dividend will be the 301st consecutive quarterly dividend paid by Pfizer.
     
    “The dividend increase is a testament to our continued commitment to returning capital to shareholders and our confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer.  “As always, we are focused on maximizing total shareholder return, of which the dividend is a key component.”
     
    About Pfizer Inc.
    At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.  We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.  Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.  For more than 150 years, Pfizer has worked to make a difference for all who rely on us.  To learn more, please visit us at www.pfizer.com.
     
    # # # # # 
     
    Media Contact:
    Joan Campion
    (212) 733-2798
     
    Investor Contact:
    Ryan Crowe
    (212) 733-8160
    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now Details